Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001209191-22-045189

Options or other derivatives

  • SVP, GC and Corporate Affairs acquired 18,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kwon SoYoung SVP, GC and Corporate Affairs 2022-08-09 Grant or award · Restricted Stock Unit +18,750 18,750 D
Loading xslF345X03/doc4.xml…